Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed ...

A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial ...

Seven scientists with the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium received another year of ...

NEW YORK and CAMBRIDGE, Mass., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative ...

Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% ...

Working with Varian, a key player in EBRT, Telix will explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment. The ...

The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five years.PPF is a ...

Onc Nurse On Call is the new podcast by Oncology Nursing News, hosted by editors-in-chief Patricia Jakel, MN, RN, AOCN, and ...

Emulsifiers are among the most common food additives. But they appear to negatively affect GI health. Should patients with GI conditions stop eating these nearly ubiquitous products?

The advertising watchdog exposed one ad for suggesting patients could “skip the doctors” with an at-home PSA test ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Loaves & Fishes Community Services has won a $5 million ...

Florida is suing three major medical associations, including the American Academy of Pediatrics, accusing them of pushing ...